http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107260752-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2017-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107260752-B |
| titleOfInvention | Synergistic anti-pancreatic cancer pharmaceutical composition |
| abstract | The invention provides a pharmaceutical composition for synergistic pancreatic cancer resistance, which comprises an active ingredient and pharmaceutically acceptable auxiliary materials, and is characterized in that the active ingredient comprises gemcitabine and a triterpene compound, wherein the triterpene compound is 3 α,11 α -dihydroxy-lupin-20 (29) -ene-28-acid or 3 α -hydroxy-lupin-20 (29) -ene-23, 28-diacid. |
| priorityDate | 2017-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.